Wednesday, August 15, 2018


Tuesday, September 19, 2017

SESSION 1: Cancer Policies and the Cost of Precenting, Researching and Treating Cancer
  • Policy Initiatives and Policy Issues Associated with Cancer Prevention and Treatment
  • The role of the European Reference Networks
  • The necessity of registries for oncology in Greece
  • The economic aspect of Cancer Treatment and the benefits for the National Healthcare System
  • Propositions of Defining and Measuring Value in Cancer Care
  • Towards a National Cancer Strategy
SESSION 2: Innovation in Cancer Research & Treatment

Keynote Speech:
The new Precision Medicine Infrastructure Project in Greece

  • Legal Framework for the use of the Innovative Therapies in Cancer Treatment
  • Assessments of Oncology drug pricing and reimbursement policies
  • Orphan Drugs &Companion Diagnostics
  • The Evolution of Clinical Trials in Oncology
SESSION 3: Personalised and Targeted Therapies & the Use of Biomarkers
  • The value of Personalized Medicine and Access Problems in the Greek healthcare system
  • Access to Personalized Therapies with the use of Biomarkers
  • Liquid biopsies and the optimal use of biomarkers
  • Biomarker tests, quality criteria and accreditation of diagnostic laboratories
  • GDRP and the use of Personal Data

The program is under development.


© 2018 Boussias Communications, all rights reserved., T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team